Product Information
BUPRENORPHINE-NALOXONE 4-1 MG SL FILM is a generic product labeled by Alvogen Inc., priced at $2.5307 per EA under NDC 47781035603. Its NADAC has been published 379 times since May 22, 2019.
FDA first approved this application on Jan 24, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4; 1 mg/1; mg/1
Manufacturer
Alvogen Inc.NDC
47781035603
Classification
Generic
Dosage Form
FILM
Route
BUCCAL; SUBLINGUAL
Effective Date
8/19/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA205954FDA Approved
1/24/2019
TE Code
AB
On Market Since
2/11/2019
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE-NALOXONE 4-1 MG SL FILM has been published 379 times since May 22, 2019, and over the history we have for it it has declined 54.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.5307 per EA |
|---|---|
| All-time high | $5.5517 (Jan 15, 2020) |
| All-time low | $2.2093 (Nov 20, 2024) |
| 52-week high | $3.5744 |
| 52-week low | $2.2214 |
| Median price | $4.0662 |
| Average price | $4.1029 |
| Largest weekly change | +50.3% (Aug 21, 2024) |
| Weeks tracked | 379 |
| Tracking since | May 22, 2019 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPRENORPHINE-NALOXONE 4-1 MG SL FILM?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE-NALOXONE 4-1 MG SL FILM, manufactured by Alvogen Inc., is $2.5307 per EA (NDC 47781035603), effective Aug 19, 2026.
How has the price of BUPRENORPHINE-NALOXONE 4-1 MG SL FILM changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE-NALOXONE 4-1 MG SL FILM has declined 54.3%. It has been tracked across 379 weekly CMS publications since May 22, 2019.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE-NALOXONE 4-1 MG SL FILM?
Since May 22, 2019, the NADAC for BUPRENORPHINE-NALOXONE 4-1 MG SL FILM has ranged from a low of $2.2093 (Nov 20, 2024) to a high of $5.5517 (Jan 15, 2020), with a median of $4.0662 per EA.
Are there cheaper alternatives to BUPRENORPHINE-NALOXONE 4-1 MG SL FILM?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPRENORPHINE-NALOXONE 4-1 MG SL FILM in a comparable dosage form, but none are currently priced below it.
Who manufactures BUPRENORPHINE-NALOXONE 4-1 MG SL FILM?
BUPRENORPHINE-NALOXONE 4-1 MG SL FILM (NDC 47781035603) is labeled by Alvogen Inc., and CMS classifies it as a generic product.